Aqueous interleukin-6 levels are superior to vascular endothelial growth factor in predicting therapeutic response to bevacizumab in age-related macular degeneration

Journal of Ophthalmology

Volumn 2014, Issue , 2014, Pages

  Chalam, Kakarla V ^a   Grover, Sandeep ^a   Sambhav, Kumar ^a   Balaiya, Sankarathi ^a   Murthy, Ravi K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904616437     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2014/502174     Document Type: Article

References (22)

1. Congdon N., O'Colmain B., Klaver C. C., Causes and prevalence of visual impairment among adults in the United States. Archives of Ophthalmology 2004 122 4 477 485 10.1001/archopht.122.4.477 (Pubitemid 38456282)
2. Seddon J., Chen C., Heier J., The epidemiology of age related macular degeneration. Controversies and Advancement in the Treatment of Retinal Disease 2004 Philadelphia, Pa, USA Lippincott Williams & Wilkins 17 39 (Pubitemid 39392076)
3. Green W. R., Histopathology of age-related macular degeneration. Molecular Vision 1999 5 27 36 2-s2.0-0033520641
4. Duh E. J., Yang H. S., Haller J. A., de Juan E., Humayun M. S., Gehlbach P., Melia M., Pieramici D., Harlan J. B., Campochiaro P. A., Zack D. J., Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. American Journal of Ophthalmology 2004 137 4 668 674 10.1016/j.ajo.2003.11.015 2-s2.0-11144357806 (Pubitemid 38446681)
5. Aiello L. P., Avery R. L., Arrigg P. G., Keyt B. A., Jampel H. D., Shah S. T., Pasquale L. R., Thieme H., Iwamoto M. A., Park J. E., Nguyen H. V., Aiello L. M., Ferrara N., King G. L., Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. The New England Journal of Medicine 1994 331 22 1480 1487 10.1056/ NEJM199412013312203 2-s2.0-0027942607 (Pubitemid 24356306)
6. Gragoudas E. S., Adamis A. P., Cunningham E. T. Jr., Feinsod M., Guyer D. R., Pegaptanib for neovascular age-related macular degeneration. The New England Journal of Medicine 2004 351 27 2805 2816 10.1056/NEJMoa042760 2-s2.0-11144239923 (Pubitemid 40051904)
7. Brown D. M., Kaiser P. K., Michels M., Soubrane G., Heier J. S., Kim R. Y., Sy J. P., Schneider S., Ranibizumab versus verteporfin for neovascular age-related macular degeneration. The New England Journal of Medicine 2006 355 14 1432 1444 10.1056/NEJMoa062655 2-s2.0-33749451356 (Pubitemid 44511558)
8. Avery R. L., Pieramici D. J., Rabena M. D., Castellarin A. A., Nasir M. A., Giust M. J., Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006 113 3 363 372 10.1016/j.ophtha.2005.11. 019 2-s2.0-33644502828
9. Kijlstra A., La Heij E. C., Hendrikse F., Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocular Immunology and Inflammation 2005 13 1 3 11 10.1080/09273940590909185 2-s2.0-17844409078 (Pubitemid 41702778)
10. Kvanta A., Algvere P. V., Berglin L., Seregard S., Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Investigative Ophthalmology and Visual Science 1996 37 9 1929 1934 2-s2.0-0029831672 (Pubitemid 26324159)
11. Cohen T., Nahari D., Cerem L. W., Neufeld G., Levin B. Z., Interleukin 6 induces the expression of vascular endothelial growth factor. The Journal of Biological Chemistry 1996 271 2 736 741 10.1074/jbc.271.2.736 2-s2.0-0030046481 (Pubitemid 26034921)
12. Saidi A., Hagedorn M., Allain N., Verpelli C., Sala C., Bello L., Bikfalvi A., Javerzat S., Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness. International Journal of Cancer 2009 125 5 1054 1064 10.1002/ijc.24380 2-s2.0-67650087998
13. Seddon J. M., George S., Rosner B., Rifai N., Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005 123 6 774 782 10.1001/archopht.123.6.774 2-s2.0-20644467790 (Pubitemid 41056598)
14. Sharma R. K., Rogojina A. T., Chalam K. V., Bevacizumab therapy normalizes the pathological intraocular environment beyond neutralizing VEGF. Molecular Vision 2010 16 2175 2184 2-s2.0-78149475837
15. Chalam K. V., Balaiya S., Murthy R. K., Accurate estimation of vascular endothelial growth factor levels in microsamples with a low-cost bead-based assay. Retina 2010 30 5 815 819 10.1097/IAE.0b013e3181c70153 2-s2.0-77952272564
16. Noma H., Funatsu H., Yamasaki M., Tsukamoto H., Mimura T., Sone T., Hirayama T., Tamura H., Yamashita H., Minamoto A., Mishima H. K., Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008 22 1 42 48 10.1038/sj.eye.6702498 2-s2.0-38349179299
17. Roh M. I., Lim S. J., Ahn J. M., Lim J. B., Kwon O. W., Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection. Graefe's Archive for Clinical and Experimental Ophthalmology 2010 248 5 635 640 10.1007/s00417-009-1254-8 2-s2.0-77952094419
18. Funk M., Schmidinger G., Maar N., Bolz M., Benesch T., Zlabinger G. J., Schmidt-Erfurth U. M., Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010 30 9 1412 1419 10.1097/IAE.0b013e3181e095c0 2-s2.0-78049283701
19. Roh M. I., Kim H. S., Song J. H., Lim J. B., Koh H. J., Kwon O. W., Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed cnv associated with amd after bevacizumab treatment. Retina 2009 29 4 523 529 10.1097/IAE.0b013e318195cb15 2-s2.0-66149141458
20. Keane P. A., Liakopoulos S., Chang K. T., Wang M., Dustin L., Walsh A. C., Sadda S. R., Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration. Ophthalmology 2008 115 12 2206 2214 10.1016/j.ophtha.2008.08.016 2-s2.0-56549103834
21. Golbaz I., Ahlers C., Stock G., Schütze C., Schriefl S., Schlanitz F., Simader C., Prünte C., Schmidt-Erfurth U. M., Quantification of the therapeutic response of intraretinal, subretinal, and subpigment epithelial compartments in exudative AMD during anti-VEGF therapy. Investigative Ophthalmology & Visual Science 2011 52 3 1599 1605 10.1167/iovs.09-5018 2-s2.0-79955933661
22. Browning D. J., Fraser C. M., Propst B. W., The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema. The American Journal of Ophthalmology 2008 145 5 889 893 10.1016/j.ajo.2008.01.007 2-s2.0-43049179988